Cadile, Richard G.
HRN: 10-00-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2025
CEFTRIAXONE 1G (VIAL)
06/09/2025
06/16/2025
IV
1g
Q12
Biliary Cirrhosis Sec To Chronic Obstructive Jaundice Sec To Choledocholelithiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes